The portfolio maintains a sizable cost advantage over competitors, priced within the second-lowest fee quintile among peers.
Amplify Treatments, Testing and Adv ETF GERM
Morningstar’s Analysis GERM
Will GERM outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 53.6
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Moderna Inc | 7.64 | 694,417 | Healthcare |
Quest Diagnostics Inc | 7.20 | 654,079 | Healthcare |
BioNTech SE ADR | 6.47 | 587,981 | Healthcare |
Alnylam Pharmaceuticals Inc | 6.31 | 573,690 | Healthcare |
Laboratory Corp of America Holdings | 6.10 | 554,388 | Healthcare |
ImmunityBio Inc Ordinary Shares | 4.78 | 434,452 | Healthcare |
QuidelOrtho Corp | 3.85 | 350,026 | Healthcare |
Immunocore Holdings PLC ADR | 3.82 | 347,014 | Healthcare |
Dynavax Technologies Corp | 3.80 | 345,030 | Healthcare |
Bio-Rad Laboratories Inc Class A | 3.74 | 340,090 | Healthcare |